ARS Pharmaceuticals, Inc. earnings per share and revenue

SPRY earnings per share for the last quarter are 0.48 USD whereas the estimation was -0.24 USD which accounts for 302.11% surprise. Company revenue for the same period amounts to 86.60 M USD despite the estimated figure of 5.65 M USD. Estimated earnings per share for the next quarter are -0.34 USD, and revenue is expected to reach 7.48 M USD. Also watch annual changes over time to get a bigger picture of SPRY earnings per share and revenue dynamics.